Global Synthetic Stem Cells Market
Global Synthetic Stem Cells Market

Synthetic Stem Cells Comprehensive Study by Application (Cardiovascular Diseases, Neurological Disorders, Cancer, Diabetes, Musculoskeletal Disorders, Gastrointestinal Disorders, Ocular Disorders), Stem Cell Type (Totipotent, Pluripotent, Multipotent, Oligopotent, Unipotent), Tissue Types (The Brain, Bone Marrow, Blood and Blood Vessels, Skeletal Muscles, Skin, The Liver), End User (Pharmaceutical and Biotechnology Companies, Hospitals and Surgical Centres, Academic Institutes, Research Laboratories, Contract Research Organizations, Others) Players and Region - Global Market Outlook to 2026

Synthetic Stem Cells Market Segmented into XX Submarkets. | Forecast Years: 2021- 2026  

May 2021 Edition 207 Pages 217 Tables & Figures
  • Summary
  • Market Segments
  • Table of Content
  • List of Tables & Figures
  • Companies Mentioned
What is Synthetic Stem Cells Market Scope?
Various types of adult stem cells in regenerative medicines have generated considerable attention and interest among clinicians and industries. There has been a groundswell of interest in stem cell-targeted therapies in medicine and neurology among researchers. However, the huge therapeutic edges these have still lack substantial scientific proof and consistent clinical backing. Challenges of careful packaging and process before they're used except vital risks natural stem cells entail are factors that account for their limited therapeutic efficacy. Additionally, they suffer from restricted durability. Hence, there has been a surge in analysis on synthetic stem cells in recent years to urge over a number of these challenges. Synthetic stem cells enable flexibility in producing processes, are less delicate in handling, and might be created to bypass the system. Moreover, they need comparable therapeutic edges offered by natural stem cells in tissue repair. One in every one of the areas wherever synthetic stem cells are witnessing a large potential in cardiovascular diseases.

The Synthetic Stem Cells market study is being classified, by Application (Cardiovascular Diseases, Neurological Disorders, Cancer, Diabetes, Musculoskeletal Disorders, Gastrointestinal Disorders and Ocular Disorders) and major geographies with country level break-up.

The companies are exploring the market by adopting mergers & acquisitions, expansions, investments, new service launches, and collaborations as their preferred strategies. The players are exploring new geographies through expansions and acquisitions to avail a competitive advantage through combined synergies. Research Analyst at AMA predicts that Players from United States will contribute to the maximum growth of Global Synthetic Stem Cells market throughout the predicted period.

Athersys, Inc. (United States), BrainStorm Cell Limited (United States), Caladrius (United States), Cellular Biomedicine Group (United States), Gamida Cell (Israel), Pluristem Therapeutics Inc. (Israel), Sangamo Therapeutics (United States), ThermoGenesis Corp. (United States), Vericel Corporation (United States) and VistaGen Therapeutics, Inc. (United States) are some of the key players profiled in the study.

Segmentation Analysis
Analyst at AMA have segmented the market study of Global Synthetic Stem Cells market by Type, Application and Region.

On the basis of geography, the market of Synthetic Stem Cells has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico).




Influencing Market Trend
  • Increasing Awareness About the Synthetic Stem Cells

Market Drivers
  • Growing Number of Ethical Concerns Regarding Embryonic Stem Cells

Opportunities
  • Surging Levels of Investment for Research Activities
  • Growing Number of Applications in Major Indication

Restraints
  • Stringent Rules and Regulations

Challenges
  • Lack of Awareness


Key Target Audience
New Entrants/Investors, Analysts and Strategic Business Planners, Providers of Synthetic Stem Cells, Venture Capitalists and Private Equity Firms and End-Use Industry

Customization available in this Study:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.

To compete effectively, companies also require quantitative estimates of the future growth and qualitative nature of the market. AMA Research & Media features not just specific market sizing estimates, but also include significant value-added commentary on Technological Trends and Innovations, Regulatory Policies, Market Maturity Indicators, Market Share Movements, New Entrants into the Market & Entry/Exit Barriers, Consumer Demographics, Supporting Company Financial and Cash Flow Planning, Open Up New Markets , To Seize Powerful Market Opportunities, Key Decision in Planning and to Further Expand Market Share, Identify Key Business Segments, Market Proposition & Gap Analysis.
Report Objectives / Segmentation Covered
By Application
  • Cardiovascular Diseases
  • Neurological Disorders
  • Cancer
  • Diabetes
  • Musculoskeletal Disorders
  • Gastrointestinal Disorders
  • Ocular Disorders
By Stem Cell Type
  • Totipotent
  • Pluripotent
  • Multipotent
  • Oligopotent
  • Unipotent

By Tissue Types
  • The Brain
  • Bone Marrow
  • Blood and Blood Vessels
  • Skeletal Muscles
  • Skin
  • The Liver

By End User
  • Pharmaceutical and Biotechnology Companies
  • Hospitals and Surgical Centres
  • Academic Institutes
  • Research Laboratories
  • Contract Research Organizations
  • Others

By Regions
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Asia Pacific
    • China
    • Japan
    • India
    • South Korea
    • Taiwan
    • Australia
    • Rest of Asia-Pacific
  • Europe
    • Germany
    • France
    • Italy
    • United Kingdom
    • Netherlands
    • Rest of Europe
  • MEA
    • Middle East
    • Africa
  • North America
    • United States
    • Canada
    • Mexico
  • 1. Market Overview
    • 1.1. Introduction
    • 1.2. Scope/Objective of the Study
      • 1.2.1. Research Objective
  • 2. Executive Summary
    • 2.1. Introduction
  • 3. Market Dynamics
    • 3.1. Introduction
    • 3.2. Market Drivers
      • 3.2.1. Growing Number of Ethical Concerns Regarding Embryonic Stem Cells
    • 3.3. Market Challenges
      • 3.3.1. Lack of Awareness
    • 3.4. Market Trends
      • 3.4.1. Increasing Awareness About the Synthetic Stem Cells
  • 4. Market Factor Analysis
    • 4.1. Porters Five Forces
    • 4.2. Supply/Value Chain
    • 4.3. PESTEL analysis
    • 4.4. Market Entropy
    • 4.5. Patent/Trademark Analysis
  • 5. Global Synthetic Stem Cells, by Application, Stem Cell Type, Tissue Types, End User and Region (value and price ) (2015-2020)
    • 5.1. Introduction
    • 5.2. Global Synthetic Stem Cells (Value)
      • 5.2.1. Global Synthetic Stem Cells by: Application (Value)
        • 5.2.1.1. Cardiovascular Diseases
        • 5.2.1.2. Neurological Disorders
        • 5.2.1.3. Cancer
        • 5.2.1.4. Diabetes
        • 5.2.1.5. Musculoskeletal Disorders
        • 5.2.1.6. Gastrointestinal Disorders
        • 5.2.1.7. Ocular Disorders
      • 5.2.2. Global Synthetic Stem Cells by: Stem Cell Type (Value)
        • 5.2.2.1. Totipotent
        • 5.2.2.2. Pluripotent
        • 5.2.2.3. Multipotent
        • 5.2.2.4. Oligopotent
        • 5.2.2.5. Unipotent
      • 5.2.3. Global Synthetic Stem Cells by: Tissue Types (Value)
        • 5.2.3.1. The Brain
        • 5.2.3.2. Bone Marrow
        • 5.2.3.3. Blood and Blood Vessels
        • 5.2.3.4. Skeletal Muscles
        • 5.2.3.5. Skin
        • 5.2.3.6. The Liver
      • 5.2.4. Global Synthetic Stem Cells by: End User (Value)
        • 5.2.4.1. Pharmaceutical and Biotechnology Companies
        • 5.2.4.2. Hospitals and Surgical Centres
        • 5.2.4.3. Academic Institutes
        • 5.2.4.4. Research Laboratories
        • 5.2.4.5. Contract Research Organizations
        • 5.2.4.6. Others
      • 5.2.5. Global Synthetic Stem Cells Region
        • 5.2.5.1. South America
          • 5.2.5.1.1. Brazil
          • 5.2.5.1.2. Argentina
          • 5.2.5.1.3. Rest of South America
        • 5.2.5.2. Asia Pacific
          • 5.2.5.2.1. China
          • 5.2.5.2.2. Japan
          • 5.2.5.2.3. India
          • 5.2.5.2.4. South Korea
          • 5.2.5.2.5. Taiwan
          • 5.2.5.2.6. Australia
          • 5.2.5.2.7. Rest of Asia-Pacific
        • 5.2.5.3. Europe
          • 5.2.5.3.1. Germany
          • 5.2.5.3.2. France
          • 5.2.5.3.3. Italy
          • 5.2.5.3.4. United Kingdom
          • 5.2.5.3.5. Netherlands
          • 5.2.5.3.6. Rest of Europe
        • 5.2.5.4. MEA
          • 5.2.5.4.1. Middle East
          • 5.2.5.4.2. Africa
        • 5.2.5.5. North America
          • 5.2.5.5.1. United States
          • 5.2.5.5.2. Canada
          • 5.2.5.5.3. Mexico
    • 5.3. Global Synthetic Stem Cells (Price)
  • 6. Synthetic Stem Cells: Manufacturers/Players Analysis
    • 6.1. Competitive Landscape
      • 6.1.1. Market Share Analysis
        • 6.1.1.1. Top 3
        • 6.1.1.2. Top 5
    • 6.2. Peer Group Analysis (2020)
    • 6.3. BCG Matrix
    • 6.4. Company Profile
      • 6.4.1. Athersys, Inc. (United States)
        • 6.4.1.1. Business Overview
        • 6.4.1.2. Products/Services Offerings
        • 6.4.1.3. Financial Analysis
        • 6.4.1.4. SWOT Analysis
      • 6.4.2. BrainStorm Cell Limited (United States)
        • 6.4.2.1. Business Overview
        • 6.4.2.2. Products/Services Offerings
        • 6.4.2.3. Financial Analysis
        • 6.4.2.4. SWOT Analysis
      • 6.4.3. Caladrius (United States)
        • 6.4.3.1. Business Overview
        • 6.4.3.2. Products/Services Offerings
        • 6.4.3.3. Financial Analysis
        • 6.4.3.4. SWOT Analysis
      • 6.4.4. Cellular Biomedicine Group (United States)
        • 6.4.4.1. Business Overview
        • 6.4.4.2. Products/Services Offerings
        • 6.4.4.3. Financial Analysis
        • 6.4.4.4. SWOT Analysis
      • 6.4.5. Gamida Cell (Israel)
        • 6.4.5.1. Business Overview
        • 6.4.5.2. Products/Services Offerings
        • 6.4.5.3. Financial Analysis
        • 6.4.5.4. SWOT Analysis
      • 6.4.6. Pluristem Therapeutics Inc. (Israel)
        • 6.4.6.1. Business Overview
        • 6.4.6.2. Products/Services Offerings
        • 6.4.6.3. Financial Analysis
        • 6.4.6.4. SWOT Analysis
      • 6.4.7. Sangamo Therapeutics (United States)
        • 6.4.7.1. Business Overview
        • 6.4.7.2. Products/Services Offerings
        • 6.4.7.3. Financial Analysis
        • 6.4.7.4. SWOT Analysis
      • 6.4.8. ThermoGenesis Corp. (United States)
        • 6.4.8.1. Business Overview
        • 6.4.8.2. Products/Services Offerings
        • 6.4.8.3. Financial Analysis
        • 6.4.8.4. SWOT Analysis
      • 6.4.9. Vericel Corporation (United States)
        • 6.4.9.1. Business Overview
        • 6.4.9.2. Products/Services Offerings
        • 6.4.9.3. Financial Analysis
        • 6.4.9.4. SWOT Analysis
      • 6.4.10. VistaGen Therapeutics, Inc. (United States)
        • 6.4.10.1. Business Overview
        • 6.4.10.2. Products/Services Offerings
        • 6.4.10.3. Financial Analysis
        • 6.4.10.4. SWOT Analysis
  • 7. Global Synthetic Stem Cells Sale, by Application, Stem Cell Type, Tissue Types, End User and Region (value and price ) (2021-2026)
    • 7.1. Introduction
    • 7.2. Global Synthetic Stem Cells (Value)
      • 7.2.1. Global Synthetic Stem Cells by: Application (Value)
        • 7.2.1.1. Cardiovascular Diseases
        • 7.2.1.2. Neurological Disorders
        • 7.2.1.3. Cancer
        • 7.2.1.4. Diabetes
        • 7.2.1.5. Musculoskeletal Disorders
        • 7.2.1.6. Gastrointestinal Disorders
        • 7.2.1.7. Ocular Disorders
      • 7.2.2. Global Synthetic Stem Cells by: Stem Cell Type (Value)
        • 7.2.2.1. Totipotent
        • 7.2.2.2. Pluripotent
        • 7.2.2.3. Multipotent
        • 7.2.2.4. Oligopotent
        • 7.2.2.5. Unipotent
      • 7.2.3. Global Synthetic Stem Cells by: Tissue Types (Value)
        • 7.2.3.1. The Brain
        • 7.2.3.2. Bone Marrow
        • 7.2.3.3. Blood and Blood Vessels
        • 7.2.3.4. Skeletal Muscles
        • 7.2.3.5. Skin
        • 7.2.3.6. The Liver
      • 7.2.4. Global Synthetic Stem Cells by: End User (Value)
        • 7.2.4.1. Pharmaceutical and Biotechnology Companies
        • 7.2.4.2. Hospitals and Surgical Centres
        • 7.2.4.3. Academic Institutes
        • 7.2.4.4. Research Laboratories
        • 7.2.4.5. Contract Research Organizations
        • 7.2.4.6. Others
      • 7.2.5. Global Synthetic Stem Cells Region
        • 7.2.5.1. South America
          • 7.2.5.1.1. Brazil
          • 7.2.5.1.2. Argentina
          • 7.2.5.1.3. Rest of South America
        • 7.2.5.2. Asia Pacific
          • 7.2.5.2.1. China
          • 7.2.5.2.2. Japan
          • 7.2.5.2.3. India
          • 7.2.5.2.4. South Korea
          • 7.2.5.2.5. Taiwan
          • 7.2.5.2.6. Australia
          • 7.2.5.2.7. Rest of Asia-Pacific
        • 7.2.5.3. Europe
          • 7.2.5.3.1. Germany
          • 7.2.5.3.2. France
          • 7.2.5.3.3. Italy
          • 7.2.5.3.4. United Kingdom
          • 7.2.5.3.5. Netherlands
          • 7.2.5.3.6. Rest of Europe
        • 7.2.5.4. MEA
          • 7.2.5.4.1. Middle East
          • 7.2.5.4.2. Africa
        • 7.2.5.5. North America
          • 7.2.5.5.1. United States
          • 7.2.5.5.2. Canada
          • 7.2.5.5.3. Mexico
    • 7.3. Global Synthetic Stem Cells (Price)
  • 8. Appendix
    • 8.1. Acronyms
  • 9. Methodology and Data Source
    • 9.1. Methodology/Research Approach
      • 9.1.1. Research Programs/Design
      • 9.1.2. Market Size Estimation
      • 9.1.3. Market Breakdown and Data Triangulation
    • 9.2. Data Source
      • 9.2.1. Secondary Sources
      • 9.2.2. Primary Sources
    • 9.3. Disclaimer
List of Tables
  • Table 1. Synthetic Stem Cells: by Application(USD Million)
  • Table 2. Synthetic Stem Cells Cardiovascular Diseases , by Region USD Million (2015-2020)
  • Table 3. Synthetic Stem Cells Neurological Disorders , by Region USD Million (2015-2020)
  • Table 4. Synthetic Stem Cells Cancer , by Region USD Million (2015-2020)
  • Table 5. Synthetic Stem Cells Diabetes , by Region USD Million (2015-2020)
  • Table 6. Synthetic Stem Cells Musculoskeletal Disorders , by Region USD Million (2015-2020)
  • Table 7. Synthetic Stem Cells Gastrointestinal Disorders , by Region USD Million (2015-2020)
  • Table 8. Synthetic Stem Cells Ocular Disorders , by Region USD Million (2015-2020)
  • Table 9. Synthetic Stem Cells: by Stem Cell Type(USD Million)
  • Table 10. Synthetic Stem Cells Totipotent , by Region USD Million (2015-2020)
  • Table 11. Synthetic Stem Cells Pluripotent , by Region USD Million (2015-2020)
  • Table 12. Synthetic Stem Cells Multipotent , by Region USD Million (2015-2020)
  • Table 13. Synthetic Stem Cells Oligopotent , by Region USD Million (2015-2020)
  • Table 14. Synthetic Stem Cells Unipotent , by Region USD Million (2015-2020)
  • Table 15. Synthetic Stem Cells: by Tissue Types(USD Million)
  • Table 16. Synthetic Stem Cells The Brain , by Region USD Million (2015-2020)
  • Table 17. Synthetic Stem Cells Bone Marrow , by Region USD Million (2015-2020)
  • Table 18. Synthetic Stem Cells Blood and Blood Vessels , by Region USD Million (2015-2020)
  • Table 19. Synthetic Stem Cells Skeletal Muscles , by Region USD Million (2015-2020)
  • Table 20. Synthetic Stem Cells Skin , by Region USD Million (2015-2020)
  • Table 21. Synthetic Stem Cells The Liver , by Region USD Million (2015-2020)
  • Table 22. Synthetic Stem Cells: by End User(USD Million)
  • Table 23. Synthetic Stem Cells Pharmaceutical and Biotechnology Companies , by Region USD Million (2015-2020)
  • Table 24. Synthetic Stem Cells Hospitals and Surgical Centres , by Region USD Million (2015-2020)
  • Table 25. Synthetic Stem Cells Academic Institutes , by Region USD Million (2015-2020)
  • Table 26. Synthetic Stem Cells Research Laboratories , by Region USD Million (2015-2020)
  • Table 27. Synthetic Stem Cells Contract Research Organizations , by Region USD Million (2015-2020)
  • Table 28. Synthetic Stem Cells Others , by Region USD Million (2015-2020)
  • Table 29. South America Synthetic Stem Cells, by Country USD Million (2015-2020)
  • Table 30. South America Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 31. South America Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 32. South America Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 33. South America Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 34. Brazil Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 35. Brazil Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 36. Brazil Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 37. Brazil Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 38. Argentina Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 39. Argentina Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 40. Argentina Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 41. Argentina Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 42. Rest of South America Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 43. Rest of South America Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 44. Rest of South America Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 45. Rest of South America Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 46. Asia Pacific Synthetic Stem Cells, by Country USD Million (2015-2020)
  • Table 47. Asia Pacific Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 48. Asia Pacific Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 49. Asia Pacific Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 50. Asia Pacific Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 51. China Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 52. China Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 53. China Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 54. China Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 55. Japan Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 56. Japan Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 57. Japan Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 58. Japan Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 59. India Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 60. India Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 61. India Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 62. India Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 63. South Korea Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 64. South Korea Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 65. South Korea Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 66. South Korea Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 67. Taiwan Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 68. Taiwan Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 69. Taiwan Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 70. Taiwan Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 71. Australia Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 72. Australia Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 73. Australia Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 74. Australia Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 75. Rest of Asia-Pacific Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 76. Rest of Asia-Pacific Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 77. Rest of Asia-Pacific Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 78. Rest of Asia-Pacific Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 79. Europe Synthetic Stem Cells, by Country USD Million (2015-2020)
  • Table 80. Europe Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 81. Europe Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 82. Europe Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 83. Europe Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 84. Germany Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 85. Germany Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 86. Germany Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 87. Germany Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 88. France Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 89. France Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 90. France Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 91. France Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 92. Italy Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 93. Italy Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 94. Italy Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 95. Italy Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 96. United Kingdom Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 97. United Kingdom Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 98. United Kingdom Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 99. United Kingdom Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 100. Netherlands Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 101. Netherlands Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 102. Netherlands Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 103. Netherlands Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 104. Rest of Europe Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 105. Rest of Europe Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 106. Rest of Europe Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 107. Rest of Europe Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 108. MEA Synthetic Stem Cells, by Country USD Million (2015-2020)
  • Table 109. MEA Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 110. MEA Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 111. MEA Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 112. MEA Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 113. Middle East Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 114. Middle East Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 115. Middle East Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 116. Middle East Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 117. Africa Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 118. Africa Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 119. Africa Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 120. Africa Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 121. North America Synthetic Stem Cells, by Country USD Million (2015-2020)
  • Table 122. North America Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 123. North America Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 124. North America Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 125. North America Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 126. United States Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 127. United States Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 128. United States Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 129. United States Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 130. Canada Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 131. Canada Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 132. Canada Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 133. Canada Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 134. Mexico Synthetic Stem Cells, by Application USD Million (2015-2020)
  • Table 135. Mexico Synthetic Stem Cells, by Stem Cell Type USD Million (2015-2020)
  • Table 136. Mexico Synthetic Stem Cells, by Tissue Types USD Million (2015-2020)
  • Table 137. Mexico Synthetic Stem Cells, by End User USD Million (2015-2020)
  • Table 138. Company Basic Information, Sales Area and Its Competitors
  • Table 139. Company Basic Information, Sales Area and Its Competitors
  • Table 140. Company Basic Information, Sales Area and Its Competitors
  • Table 141. Company Basic Information, Sales Area and Its Competitors
  • Table 142. Company Basic Information, Sales Area and Its Competitors
  • Table 143. Company Basic Information, Sales Area and Its Competitors
  • Table 144. Company Basic Information, Sales Area and Its Competitors
  • Table 145. Company Basic Information, Sales Area and Its Competitors
  • Table 146. Company Basic Information, Sales Area and Its Competitors
  • Table 147. Company Basic Information, Sales Area and Its Competitors
  • Table 148. Synthetic Stem Cells: by Application(USD Million)
  • Table 149. Synthetic Stem Cells Cardiovascular Diseases , by Region USD Million (2021-2026)
  • Table 150. Synthetic Stem Cells Neurological Disorders , by Region USD Million (2021-2026)
  • Table 151. Synthetic Stem Cells Cancer , by Region USD Million (2021-2026)
  • Table 152. Synthetic Stem Cells Diabetes , by Region USD Million (2021-2026)
  • Table 153. Synthetic Stem Cells Musculoskeletal Disorders , by Region USD Million (2021-2026)
  • Table 154. Synthetic Stem Cells Gastrointestinal Disorders , by Region USD Million (2021-2026)
  • Table 155. Synthetic Stem Cells Ocular Disorders , by Region USD Million (2021-2026)
  • Table 156. Synthetic Stem Cells: by Stem Cell Type(USD Million)
  • Table 157. Synthetic Stem Cells Totipotent , by Region USD Million (2021-2026)
  • Table 158. Synthetic Stem Cells Pluripotent , by Region USD Million (2021-2026)
  • Table 159. Synthetic Stem Cells Multipotent , by Region USD Million (2021-2026)
  • Table 160. Synthetic Stem Cells Oligopotent , by Region USD Million (2021-2026)
  • Table 161. Synthetic Stem Cells Unipotent , by Region USD Million (2021-2026)
  • Table 162. Synthetic Stem Cells: by Tissue Types(USD Million)
  • Table 163. Synthetic Stem Cells The Brain , by Region USD Million (2021-2026)
  • Table 164. Synthetic Stem Cells Bone Marrow , by Region USD Million (2021-2026)
  • Table 165. Synthetic Stem Cells Blood and Blood Vessels , by Region USD Million (2021-2026)
  • Table 166. Synthetic Stem Cells Skeletal Muscles , by Region USD Million (2021-2026)
  • Table 167. Synthetic Stem Cells Skin , by Region USD Million (2021-2026)
  • Table 168. Synthetic Stem Cells The Liver , by Region USD Million (2021-2026)
  • Table 169. Synthetic Stem Cells: by End User(USD Million)
  • Table 170. Synthetic Stem Cells Pharmaceutical and Biotechnology Companies , by Region USD Million (2021-2026)
  • Table 171. Synthetic Stem Cells Hospitals and Surgical Centres , by Region USD Million (2021-2026)
  • Table 172. Synthetic Stem Cells Academic Institutes , by Region USD Million (2021-2026)
  • Table 173. Synthetic Stem Cells Research Laboratories , by Region USD Million (2021-2026)
  • Table 174. Synthetic Stem Cells Contract Research Organizations , by Region USD Million (2021-2026)
  • Table 175. Synthetic Stem Cells Others , by Region USD Million (2021-2026)
  • Table 176. South America Synthetic Stem Cells, by Country USD Million (2021-2026)
  • Table 177. South America Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 178. South America Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 179. South America Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 180. South America Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 181. Brazil Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 182. Brazil Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 183. Brazil Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 184. Brazil Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 185. Argentina Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 186. Argentina Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 187. Argentina Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 188. Argentina Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 189. Rest of South America Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 190. Rest of South America Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 191. Rest of South America Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 192. Rest of South America Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 193. Asia Pacific Synthetic Stem Cells, by Country USD Million (2021-2026)
  • Table 194. Asia Pacific Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 195. Asia Pacific Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 196. Asia Pacific Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 197. Asia Pacific Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 198. China Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 199. China Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 200. China Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 201. China Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 202. Japan Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 203. Japan Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 204. Japan Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 205. Japan Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 206. India Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 207. India Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 208. India Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 209. India Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 210. South Korea Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 211. South Korea Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 212. South Korea Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 213. South Korea Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 214. Taiwan Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 215. Taiwan Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 216. Taiwan Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 217. Taiwan Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 218. Australia Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 219. Australia Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 220. Australia Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 221. Australia Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 222. Rest of Asia-Pacific Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 223. Rest of Asia-Pacific Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 224. Rest of Asia-Pacific Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 225. Rest of Asia-Pacific Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 226. Europe Synthetic Stem Cells, by Country USD Million (2021-2026)
  • Table 227. Europe Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 228. Europe Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 229. Europe Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 230. Europe Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 231. Germany Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 232. Germany Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 233. Germany Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 234. Germany Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 235. France Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 236. France Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 237. France Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 238. France Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 239. Italy Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 240. Italy Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 241. Italy Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 242. Italy Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 243. United Kingdom Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 244. United Kingdom Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 245. United Kingdom Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 246. United Kingdom Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 247. Netherlands Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 248. Netherlands Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 249. Netherlands Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 250. Netherlands Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 251. Rest of Europe Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 252. Rest of Europe Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 253. Rest of Europe Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 254. Rest of Europe Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 255. MEA Synthetic Stem Cells, by Country USD Million (2021-2026)
  • Table 256. MEA Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 257. MEA Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 258. MEA Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 259. MEA Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 260. Middle East Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 261. Middle East Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 262. Middle East Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 263. Middle East Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 264. Africa Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 265. Africa Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 266. Africa Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 267. Africa Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 268. North America Synthetic Stem Cells, by Country USD Million (2021-2026)
  • Table 269. North America Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 270. North America Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 271. North America Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 272. North America Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 273. United States Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 274. United States Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 275. United States Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 276. United States Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 277. Canada Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 278. Canada Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 279. Canada Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 280. Canada Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 281. Mexico Synthetic Stem Cells, by Application USD Million (2021-2026)
  • Table 282. Mexico Synthetic Stem Cells, by Stem Cell Type USD Million (2021-2026)
  • Table 283. Mexico Synthetic Stem Cells, by Tissue Types USD Million (2021-2026)
  • Table 284. Mexico Synthetic Stem Cells, by End User USD Million (2021-2026)
  • Table 285. Research Programs/Design for This Report
  • Table 286. Key Data Information from Secondary Sources
  • Table 287. Key Data Information from Primary Sources
List of Figures
  • Figure 1. Porters Five Forces
  • Figure 2. Supply/Value Chain
  • Figure 3. PESTEL analysis
  • Figure 4. Global Synthetic Stem Cells: by Application USD Million (2015-2020)
  • Figure 5. Global Synthetic Stem Cells: by Stem Cell Type USD Million (2015-2020)
  • Figure 6. Global Synthetic Stem Cells: by Tissue Types USD Million (2015-2020)
  • Figure 7. Global Synthetic Stem Cells: by End User USD Million (2015-2020)
  • Figure 8. South America Synthetic Stem Cells Share (%), by Country
  • Figure 9. Asia Pacific Synthetic Stem Cells Share (%), by Country
  • Figure 10. Europe Synthetic Stem Cells Share (%), by Country
  • Figure 11. MEA Synthetic Stem Cells Share (%), by Country
  • Figure 12. North America Synthetic Stem Cells Share (%), by Country
  • Figure 13. Global Synthetic Stem Cells share by Players 2020 (%)
  • Figure 14. Global Synthetic Stem Cells share by Players (Top 3) 2020(%)
  • Figure 15. Global Synthetic Stem Cells share by Players (Top 5) 2020(%)
  • Figure 16. BCG Matrix for key Companies
  • Figure 17. Athersys, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 18. Athersys, Inc. (United States) Revenue: by Geography 2020
  • Figure 19. BrainStorm Cell Limited (United States) Revenue, Net Income and Gross profit
  • Figure 20. BrainStorm Cell Limited (United States) Revenue: by Geography 2020
  • Figure 21. Caladrius (United States) Revenue, Net Income and Gross profit
  • Figure 22. Caladrius (United States) Revenue: by Geography 2020
  • Figure 23. Cellular Biomedicine Group (United States) Revenue, Net Income and Gross profit
  • Figure 24. Cellular Biomedicine Group (United States) Revenue: by Geography 2020
  • Figure 25. Gamida Cell (Israel) Revenue, Net Income and Gross profit
  • Figure 26. Gamida Cell (Israel) Revenue: by Geography 2020
  • Figure 27. Pluristem Therapeutics Inc. (Israel) Revenue, Net Income and Gross profit
  • Figure 28. Pluristem Therapeutics Inc. (Israel) Revenue: by Geography 2020
  • Figure 29. Sangamo Therapeutics (United States) Revenue, Net Income and Gross profit
  • Figure 30. Sangamo Therapeutics (United States) Revenue: by Geography 2020
  • Figure 31. ThermoGenesis Corp. (United States) Revenue, Net Income and Gross profit
  • Figure 32. ThermoGenesis Corp. (United States) Revenue: by Geography 2020
  • Figure 33. Vericel Corporation (United States) Revenue, Net Income and Gross profit
  • Figure 34. Vericel Corporation (United States) Revenue: by Geography 2020
  • Figure 35. VistaGen Therapeutics, Inc. (United States) Revenue, Net Income and Gross profit
  • Figure 36. VistaGen Therapeutics, Inc. (United States) Revenue: by Geography 2020
  • Figure 37. Global Synthetic Stem Cells: by Application USD Million (2021-2026)
  • Figure 38. Global Synthetic Stem Cells: by Stem Cell Type USD Million (2021-2026)
  • Figure 39. Global Synthetic Stem Cells: by Tissue Types USD Million (2021-2026)
  • Figure 40. Global Synthetic Stem Cells: by End User USD Million (2021-2026)
  • Figure 41. South America Synthetic Stem Cells Share (%), by Country
  • Figure 42. Asia Pacific Synthetic Stem Cells Share (%), by Country
  • Figure 43. Europe Synthetic Stem Cells Share (%), by Country
  • Figure 44. MEA Synthetic Stem Cells Share (%), by Country
  • Figure 45. North America Synthetic Stem Cells Share (%), by Country
Some of the key companies/manufacturers profiled in the report
  • Athersys, Inc. (United States)
  • BrainStorm Cell Limited (United States)
  • Caladrius (United States)
  • Cellular Biomedicine Group (United States)
  • Gamida Cell (Israel)
  • Pluristem Therapeutics Inc. (Israel)
  • Sangamo Therapeutics (United States)
  • ThermoGenesis Corp. (United States)
  • Vericel Corporation (United States)
  • VistaGen Therapeutics, Inc. (United States)
Select License Type
Sample Report Enquiry Before Buy Request Discount

Speak with Analyst

Want to find out more about this report?

Get Free Consultation